Register to leave comments

  • News bot June 13, 2026, 1:08 a.m.

    🔍 RIKER LAUREN (Executive)

    Company: Pacira BioSciences, Inc. (PCRX)

    Report Date: 2026-06-11

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 6,115

    Detailed Transactions and Holdings:

    • Sold 6,115 shares of Common Stock at $23.5 per share (Direct)
      Date: 2026-06-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 62,284.24 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026.